<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01170780</url>
  </required_header>
  <id_info>
    <org_study_id>dx3</org_study_id>
    <nct_id>NCT01170780</nct_id>
  </id_info>
  <brief_title>Dexamethasone Versus Placebo in Optimizing the Postoperative Period After Laparoscopic Inguinal Hernia Repair</brief_title>
  <official_title>Dexamethasone Versus Placebo in Optimizing the Postoperative Period After Laparoscopic Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mette Astrup Madsen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Does corticosteroid (dexamethasone) have an effect on the postoperative period after
      laparoscopic hernia repair, when it comes to pain, postoperative nausea and vomiting and
      convalescence. This randomized, double-blinded study compares dexamethasone versus placebo.
      The patients are recommended one day of convalescence. The medicine or placebo is given
      before operation. The patients fill out questionnaire before operation and three hours after
      operation and in the following three days. The patients also register when they return to
      normal activities and work.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>August 2010</start_date>
  <completion_date type="Actual">August 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>pain during coughing</measure>
    <time_frame>day 1</time_frame>
    <description>Assessed with visual analog scale (VAS 0-100 mm)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>pain during coughing</measure>
    <time_frame>4 days</time_frame>
    <description>Assessed with VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain at rest</measure>
    <time_frame>4 days</time_frame>
    <description>Assessed with VAS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>convalescence</measure>
    <time_frame>1 month</time_frame>
    <description>Registration of number of days after operation before returning to work and recreational activities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pain at rest</measure>
    <time_frame>4 days</time_frame>
    <description>Assessed with verbal rating scale (VRS:no pain, mild pain, severe pain, worst thinkable pain)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>nausea</measure>
    <time_frame>2 days</time_frame>
    <description>Assessed with verbal rating scale (VRS: no nausea, mild nausea, severe nausea, worst thinkable nausea)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vomiting</measure>
    <time_frame>2 days</time_frame>
    <description>yes/no question. If yes, how many times have you been vomiting?</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>discomfort</measure>
    <time_frame>4 days</time_frame>
    <description>Assessed with visual analog scale (VAS, 0-100 mm)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fatigue</measure>
    <time_frame>4 days</time_frame>
    <description>Assessed with numeric rating scale (NRS, 1-10)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Inguinal Hernia</condition>
  <condition>Femoral Hernia</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexamethasone</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Corticosteroid (Fortecontin 8 mg)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>single use of dexamethasone IV 8 mg/2 ml</description>
    <arm_group_label>Dexamethasone</arm_group_label>
    <other_name>Fortecontin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>2 ml IV</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>Natriumchlorid, B. Braun 9 mg/ml</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients planned for elective laparoscopic hernia repair (TAPP)

          -  Unilateral inguinal or femoral hernia

          -  ASA class I-II

          -  Read and speak Danish

        Exclusion Criteria:

          -  Acute hernia operation

          -  Operation for other hernias with mesh during the same procedure

          -  Endocrine disease (diabetes, adrenal insufficiency etc.)

          -  fever/infection within the first 10 days before operation

          -  Poor compliance

          -  No signed consent form

          -  Daily intake of opioids or anxiolytic drugs

          -  Manic episodes

          -  Use medicine against glaucoma

          -  Use thiazide or loop diuretics

          -  Vaccination within the last 14 days
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mette A Tolver, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Koege</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Thue Bisgaard, M.D. DMSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Koege</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University Hospital Koege</name>
      <address>
        <city>Koege</city>
        <zip>4600</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>January 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 26, 2010</study_first_submitted>
  <study_first_submitted_qc>July 26, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 27, 2010</study_first_posted>
  <last_update_submitted>January 26, 2012</last_update_submitted>
  <last_update_submitted_qc>January 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 31, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Zealand University Hospital</investigator_affiliation>
    <investigator_full_name>Mette Astrup Madsen</investigator_full_name>
    <investigator_title>M.D.</investigator_title>
  </responsible_party>
  <keyword>Inguinal hernia</keyword>
  <keyword>Transabdominal preperitoneal hernia repair</keyword>
  <keyword>TAPP</keyword>
  <keyword>Dexamethasone</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hernia</mesh_term>
    <mesh_term>Hernia, Inguinal</mesh_term>
    <mesh_term>Hernia, Femoral</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

